Reset Map3 Results
5155 Financial Way Suite 17 Mason, Ohio, 45040 United StatesIntroduction of Comprehensive Pathway Analysis (CPA) CPA is a biology-driven data analytics platform that provides functional pathway analysis to identify and quantify the cell signaling pathways that drive disease. Our RNAseq-based platform utilizes FASTQ bulk whole transcriptome RNAseq files or gene expression data to determine signal transduction pathway activity in a quantitative and easy interpretable manner. Using our CPA platform, our partners will be able to study up to a dozen signal transduction pathway activities and analyze potential differences in pathway activity between samples. This innovative solution aims to provide diagnostic, pharmaceutical, and biopharma partners with enhanced data insights, facilitating faster, more accurate disease drivers that enable the development of targeted therapies and diagnostic tests to improve patient outcomes. InnoSIGN’s CPA offers the first quantifiable analysis of functional pathways across major diseases. Our pathways models were constructed using a biology-driven, holistic approach, looking at relevant target genes, rather than based on data driven knowledge and are designed to be applicable in multiple tissues, providing functional, pan-disease insights. Enriching existing RNAseq analysis with Insights into Disease Driving Pathway Activity The goal of CPA is to facilitate a deeper understanding by empowering existing industry players to enrich partner information on top of the existing industry (diagnostic) assays, biopharma and drug development. CPA will provide enhanced insights and thereby allows the healthcare space, and ultimately patients, to combat some of the most challenging diseases of our time. Leveraging our own existing database containing data from different diseases and tissue types, the potential value of CPA can be explored with various directions of interest.
High Tech Campus 11 Eindhoven, 5656AE NetherlandsIntroduction of Comprehensive Pathway Analysis (CPA) CPA is a biology-driven data analytics platform that provides functional pathway analysis to identify and quantify the cell signaling pathways that drive disease. Our RNAseq-based platform utilizes FASTQ bulk whole transcriptome RNAseq files or gene expression data to determine signal transduction pathway activity in a quantitative and easy interpretable manner. Using our CPA platform, our partners will be able to study up to a dozen signal transduction pathway activities and analyze potential differences in pathway activity between samples. This innovative solution aims to provide diagnostic, pharmaceutical, and biopharma partners with enhanced data insights, facilitating faster, more accurate disease drivers that enable the development of targeted therapies and diagnostic tests to improve patient outcomes. InnoSIGN’s CPA offers the first quantifiable analysis of functional pathways across major diseases. Our pathways models were constructed using a biology-driven, holistic approach, looking at relevant target genes, rather than based on data driven knowledge and are designed to be applicable in multiple tissues, providing functional, pan-disease insights. Enriching existing RNAseq analysis with Insights into Disease Driving Pathway Activity The goal of CPA is to facilitate a deeper understanding by empowering existing industry players to enrich partner information on top of the existing industry (diagnostic) assays, biopharma and drug development. CPA will provide enhanced insights and thereby allows the healthcare space, and ultimately patients, to combat some of the most challenging diseases of our time. Leveraging our own existing database containing data from different diseases and tissue types, the potential value of CPA can be explored with various directions of interest.
5155 Financial Way Suite 17 Mason, OH, 45040 United StatesIntroduction of Comprehensive Pathway Analysis (CPA) CPA is a biology-driven data analytics platform that provides functional pathway analysis to identify and quantify the cell signaling pathways that drive disease. Our RNAseq-based platform utilizes FASTQ bulk whole transcriptome RNAseq files or gene expression data to determine signal transduction pathway activity in a quantitative and easy interpretable manner. Using our CPA platform, our partners will be able to study up to a dozen signal transduction pathway activities and analyze potential differences in pathway activity between samples. This innovative solution aims to provide diagnostic, pharmaceutical, and biopharma partners with enhanced data insights, facilitating faster, more accurate disease drivers that enable the development of targeted therapies and diagnostic tests to improve patient outcomes. InnoSIGN’s CPA offers the first quantifiable analysis of functional pathways across major diseases. Our pathways models were constructed using a biology-driven, holistic approach, looking at relevant target genes, rather than based on data driven knowledge and are designed to be applicable in multiple tissues, providing functional, pan-disease insights. Enriching existing RNAseq analysis with Insights into Disease Driving Pathway Activity The goal of CPA is to facilitate a deeper understanding by empowering existing industry players to enrich partner information on top of the existing industry (diagnostic) assays, biopharma and drug development. CPA will provide enhanced insights and thereby allows the healthcare space, and ultimately patients, to combat some of the most challenging diseases of our time. Leveraging our own existing database containing data from different diseases and tissue types, the potential value of CPA can be explored with various directions of interest.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.